Lin Tian Selected Research

Lin Tian Research Topics

Disease

31	Neoplasms (Cancer) 06/2022 - 07/2009
14	Fibrosis (Cirrhosis) 07/2022 - 11/2008
13	Schizophrenia (Dementia Praecox) 11/2022 - 04/2013
11	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2022 - 07/2009
10	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2014
9	Silicosis 03/2022 - 10/2013
8	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2015
5	Chronic Obstructive Pulmonary Disease (COPD) 07/2021 - 02/2014
5	Infections 02/2021 - 12/2010
4	Carcinoma (Carcinomatosis) 05/2021 - 05/2007
4	Inflammation (Inflammations) 03/2020 - 01/2014
3	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 05/2012
3	Fever (Fevers) 02/2021 - 12/2013
3	Lymphatic Metastasis 01/2021 - 11/2015
3	Neoplasm Micrometastasis 01/2019 - 01/2017
3	Hematologic Neoplasms (Hematological Malignancy) 06/2014 - 06/2014
3	Poisoning 06/2014 - 02/2014
2	Flatulence 01/2022 - 01/2021
2	Pathologic Processes 12/2021 - 06/2014
2	Diabetes Mellitus 09/2021 - 07/2014
2	COVID-19 01/2021 - 09/2020
2	Mental Disorders (Mental Disorder) 12/2020 - 10/2020
2	Wounds and Injuries (Trauma) 08/2020 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 10/2019 - 01/2017
2	Acute Lung Injury 10/2018 - 07/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2018 - 11/2015
2	Substance-Related Disorders (Drug Abuse) 01/2018 - 01/2018
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2017 - 05/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 06/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2014 - 02/2014
2	Leukemia 06/2014 - 06/2010
2	Carcinogenesis 06/2014 - 04/2010
2	Cognitive Dysfunction 03/2014 - 09/2002
1	Dysbiosis 07/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Treatment-Resistant Schizophrenia 01/2022

Drug/Important Bio-Agent (IBA)

15	Silicon Dioxide (Silica)FDA LinkGeneric 03/2022 - 07/2009
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2004
9	Pharmaceutical PreparationsIBA 11/2022 - 01/2017
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
6	MicroRNAs (MicroRNA)IBA 07/2022 - 06/2014
6	Messenger RNA (mRNA)IBA 01/2022 - 02/2014
5	Benzene (Benzole)IBA 06/2014 - 06/2010
4	Particulate MatterIBA 07/2022 - 10/2019
4	Biological ProductsIBA 01/2022 - 01/2019
4	Long Noncoding RNAIBA 12/2021 - 06/2014
3	Mitogen-Activated Protein KinasesIBA 07/2021 - 01/2014
3	Cyclin D1IBA 05/2021 - 01/2014
3	CytokinesIBA 01/2021 - 03/2020
3	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2016
3	CollagenIBA 11/2020 - 01/2016
3	Hydroxyproline (4 Hydroxyproline)IBA 01/2017 - 10/2013
3	Bone Morphogenetic Protein 7IBA 05/2016 - 07/2013
3	CarcinogensIBA 06/2010 - 07/2009
2	EnzymesIBA 11/2022 - 01/2022
2	AntigensIBA 06/2022 - 11/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2021
2	Insulin (Novolin)FDA Link 12/2021 - 01/2021
2	NF-kappa B (NF-kB)IBA 07/2021 - 01/2019
2	Cadherins (E-Cadherin)IBA 05/2021 - 02/2015
2	Caspase 3 (Caspase-3)IBA 05/2021 - 01/2014
2	BerberineIBA 01/2021 - 10/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2020
2	Estrogen ReceptorsIBA 01/2021 - 01/2020
2	Air Pollutants (Pollutants, Air)IBA 01/2021 - 01/2019
2	ThioredoxinsIBA 11/2020 - 10/2013
2	AntioxidantsIBA 11/2020 - 01/2019
2	Dopamine (Intropin)FDA LinkGeneric 10/2020 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2020 - 12/2013
2	mouse MIRN29 microRNAIBA 03/2019 - 11/2017
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019 - 07/2016
2	danusertibIBA 11/2018 - 01/2017
2	Everolimus FDA Link 11/2018 - 02/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 01/2017
2	Therapeutic UsesIBA 07/2017 - 01/2017
2	VaccinesIBA 01/2017 - 12/2010
2	DNA (Deoxyribonucleic Acid)IBA 06/2014 - 04/2013
1	Amisulpride (Solian)IBA 11/2022
1	Hormones (Hormone)IBA 11/2022
1	LipidsIBA 11/2022
1	Ribosomal DNA (rDNA)IBA 07/2022
1	CyclinsIBA 06/2022
1	Transforming Growth Factor-beta Type I ReceptorIBA 03/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	BilirubinIBA 01/2022
1	MetalsIBA 01/2022
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2022
1	Heavy MetalsIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	CadmiumIBA 01/2022

Therapy/Procedure

9	Therapeutics 01/2022 - 04/2013
4	Immunotherapy 06/2022 - 09/2020
3	Length of Stay 01/2022 - 12/2013
1	Gastrectomy 01/2022
1	Conscious Sedation 01/2022
1	Acupuncture Points (Acupuncture Point) 01/2022
1	Deep Sedation 01/2022